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Introduction
Gene regulation needs to be harmoniously controlled to allow precise appropriate mammalian development of embryonic and extraembryonic structures such as the placenta and foetal membranes. The amnion and chorion are foetal membranes involved in many physiological processes during pregnancy, such as protection and nutrition of the developing foetus, amniotic fluid homeostasis and parturition. These membranes form a highly specialized interface between mother and foetus and are absolutely essential to an optimal pregnancy outcome. They could also be involved in human obstetrical pathologies such as chorioamnionitis, oligohydramnios or pre-term pre-labour rupture of membranes (PPROM) [1] . The amnion consists mostly of a single layer of epithelial cells (amniocytes) on a thick basement membrane and a spongy collagen layer containing mesenchymal cells [2] . The chorion is a more opaque membrane attached to the maternal decidua containing trophoblastic cells. These layers mainly comprise extracellular matrix (ECM) proteins such as different collagen types, laminin, fibronectin and proteoglycans [3] . This complex framework allows optimal membrane resistance during pregnancy by increasing both the tensile strength and the elasticity of the foetal membranes [4] . During or just prior to labour, the breakdown of these proteins is regulated by the matrix metalloproteinases (MMPs) system [5] . These biochemical changes and the architectural disorganization of the foetal membranes reduce their integrity and elasticity, leading to membrane weakening and rupture, heralding the initiation of parturition [6] .
The plasminogen activator system, which includes tissue-type plasminogen activator (t-PA), plays an important role in the regulation of MMP activities [7, 8] [9, 10] . The molecular mechanism regulating t-PA expression in amniotic membranes remains unknown. However, retinoic acid (RA) increases t-PA expression in human umbilical vein epithelial cells (HUVEC) [11] , blood mononuclear cells [12] , astrocytes [13] , teratocarcinoma [14] , fibrosarcoma and osteocarcinoma cell lines [15] . [17] . The implications of retinoids in terms of placental development and physiology have been clearly established [18] . Moving on from our previous demonstration that the molecular and metabolic actors of retinoid signalling pathways are functional in human foetal membranes [19] , the first aim of our study was to establish the regulation of t-PA gene expression by RA in this extraembryonic environment. The second aim of this study was to identify the different actors involved in this amniotic retinoid regulation of t-PA. [21] .
Retinoids, including retinol (vitamin A) and its active metabolites all-trans and 9-cis retinoic acid (atRA and 9cisRA, respectively), play an important role in the control of cell proliferation and differentiation, particularly during embryonic and placental development [16]. Retinoids mediate their action by binding two families of nuclear receptors named retinoic acid receptors, or RARs (RAR-␣, -␤ and -␥), and retinoid X receptors, or RXRs (RXR-␣, -␤ and -␥). These receptors act as ligand-activated transcription factors and form heterodimers RAR/RXR binding DNA response element (RARE) located on specific target genes

Materials and methods
Chemicals and reagents
Cell and tissue culture
Both the amnion explants and the human amnion-derived Wistar Institute Susan Hayflick (WISH) epithelial cell line cultures were conducted as previously described [19] . 
Quantitative RT-PCR experiments
Plasmid construction
For t-PA promoter analysis (see Fig. 2A [23, 24] . Plasmid pDR5-tk-CAT contains two copies of the RA-responsive element DR5 [25] . To 
Chromatin immunoprecipitation assay
5Ј -GACCTGGAAGTCC AACT ACT-3Ј 5Ј-GTGATATCAAGCACTTCAGG-3Ј 600
XDR5t-PA 5Ј -AGGTCTGAGTGATCTCATTG-3Ј 5Ј-ACAAT AACC AAAACCAAGTG-3Ј 151 XDR5RAR-␤ 5Ј -CTCTCTGGCTGTCTGCTTTT-3Ј 5Ј-GGCAAAGAATAGACCCTCCT-3Ј 233
Primers for mutagenesis (Fig. 3A) . Using RT-PCR, we showed that SP1 was expressed in the amnion and WISH cells as in the placenta, which was used as a positive control [28] . To examine retinoid action on SP1 factor, the amnion and WISH cells were treated for 12 and 24 hrs by atRA and/or 9cisRA. qRT-PCR showed that atRA and/or 9cisRA had no effect on SP1 mRNA levels in the amnion (Fig. 3B ) or in WISH cells (Fig. 3C) Fig. 4(D 
Retinoid transactivation of t-PA is regulated by a two-step pathway in amnion
3D), indicating that the Ϫ7248/Ϫ7238 SP1 binding motif is important for retinoid regulation of the t-PA gene. Previous studies have demonstrated a physical interaction between RARs/RXRs and SP1 during retinoid regulation of target genes [29]. In order to test this physical interaction during amniotic regulation of t-PA by RA, immunoprecipitation assays were performed using the 24-hr retinoid-treated WISH cells transfected by the human RARs, RXR-␣ and SP1 expression vectors. Figure 3(E) showed that SP1 was co-immunoprecipitated not only with RAR-␣/RXR-␣ but also with RAR-␤, suggesting that SP1 and RARs/RXR-␣ physically interact in our cell model.
SP1, RARs and RXR-␣ bind to t-PA promoter
To examine SP1, RARs and RXR-␣ binding to their respective DNA response elements previously identified, ChIP assays were performed on WISH cells exposed to atRA and 9cisRA for different incubation periods (0, 2, 6, 12 and 24 hrs) using ChIP PCR primers designed to flank DR5 response element and SP1 binding motif located at Ϫ7 kb on t-PA promoter (Fig. 3F). The results revealed that RAR-␣ is able to bind DR5 after 6 and 12 hrs of retinoid treatment. Surprisingly, RAR-␤ (not naturally expressed in WISH cells) bound to DR5 t-PA promoter at 24 hrs. Because retinoid receptors are active as heterodimers, we tested the ability of RXR-␣ to bind to DR5 t-PA promoter. We showed that RXR-␣ binding to t-PA promoter was time dependent. Indeed, RXR-␣ weakly bound the DR5 site of t-PA promoter at 2 hrs and 12 hrs of retinoid treatment, whereas a higher enrichment of immunoprecipitated t-PA chromatin by RXR-␣ was detected at 6 and 24 hrs of retinoid exposure. Moreover, this experiment showed that SP1 binding is also time dependent, with high SP1 binding to its site at 6 hrs of retinoid treatment and weak binding at 24 hrs of retinoid exposure. Taken together, these results obtained on WISH cells suggest that retinoid regulation of t-PA gene is a dynamic process, with the first step (before 12 hrs of retinoid induction) involving RAR-␣/RXR-␣ heterodimer and SP1 factor and the second step (around 24 hrs after retinoid treatment) involving RAR-␤/RXR-␣ that replaces the earlier heterodimer, but always with SP1.
RAR-␤ expression increased after retinoid stimulation in amnion and WISH cells
RAR-␣ is able to interact with the DR5 site of RAR-␤ promoter in WISH cells
As been previously described, a DR5-type response element is present in the RAR-␤ promoter sequence [30]. To verify the ability of RAR-␣ and RXR-␣ to interact with RAR-␤ promoter in the amniotic environment, ChIP experiments were performed on WISH cells treated with retinoids at different times using primers flanking the DR5 site of the RAR-␤ promoter (Fig. 4C). The results showed that RAR-␣ and RXR-␣ were able to bind RAR-␤ DR5 at 2, 6, 12 and 24 hrs after retinoid treatment. RAR-␣ binding appeared stronger at 6 and 12 hrs. No interaction could be detected for RAR-␤ and RAR-␥ (data not shown). These results suggest that RAR-␣/RXR-␣ heterodimers are involved in RAR-␤ transactivation by retinoids in the amniotic (WISH cells) environment.
RAR-␤ is necessary for retinoid-mediated regulation of t-PA in WISH cells
To confirm the role of RAR-␤ in t-PA regulation by retinoids, WISH cells stably transfected for shRNA RAR-␤ (shRNA-RAR-␤-WISH) were established and treated with atRA and 9cisRA for 12 and 24 hrs. We first verified RAR-␤ extinction in terms of mRNA and proteins. No RAR-␤ mRNA was present at 12 hrs in shRNA-RAR-␤-WISH cells, and RAR-␤ mRNA levels decreased by approximately 70% at 24 hrs compared with shRNA-control-WISH cells. At the protein level, shRNA-RAR-␤-WISH cells showed a similar decrease of RAR-␤ proteins at 24 hrs (data not shown). t-PA mRNA and protein levels were then quantified in shRNA-RAR-␤-WISH cells retinoid-treated for 12 and 24 hrs. As shown in
Enrichment of immunoprecipitated t-PA chromatin by RARs, RXR-␣ or SP1 antibodies was specific compared with ChIP performed using IgG control antibodies. Graph represents semi-quantitative relative interaction of RAR-␣ (lozenge), RAR-␤ (square), RXR-␣ (triangle) and SP1 (circle) compared with input control (obtained from n ϭ 3 independent assays).
Fig. 3 SP1 is necessary in retinoid-mediated regulation of the t-PA gene. (A) First
RAR-␤ antagonist inhibits retinoid-mediated induction of t-PA in WISH cells
In order to confirm by a pharmacological approach that the retinoid-mediated induction of t-PA expression occurs through RAR-␤, WISH cells were treated with 10
antagonist LE135 [10] (Fig. 6) (Fig. 6A) . In the second step (Fig. 6B) [19] . [31] .
In this kind of developmental cascade, it is important to identify the molecular mechanisms of RAR-␤ activation. RAR-␤ activity could be reinforced by a time-specific phosphorylation. Indeed, it was previously established that RAR-␤ could be phosphorylated on tyrosine residues [32] . Treating HUVEC with RA increases t-PA production through a pathway that involves protein kinases [33] . The activation of protein kinase C was also recently reported to induce t-PA expression in human astrocytes [13] . The explanation for RAR-␤ induction could also be linked to the modifications in specific homeostasis and the metabolism of retinoids in foetal membranes at delivery. Indeed, we and Lachili's group demonstrated that vitamin A plasma concentrations significantly decreased at delivery compared with non-pregnant control groups [34, 35] . It was also established that at delivery, maternal ␤-carotene and vitamin A plasma concentrations were significantly higher than foetal cord blood concentrations [36] , suggesting a possible uptake of retinoid stocks to allow the physiological phenomenon linked to parturition. We could hypothesize that this metabolic context specific to parturition could produce sufficient [29] , and an identical mechanism has been also described for urokinase (UK) gene regulation [37] . Others studies have shown that RARs functionally interact with SP1 in the retinoid-mediated regulation of transglutaminase gene [38] , transforming growth factor-␤1 (TGF-␤1) [39] and retinol binding protein (RBP) gene [40] . The involvement of SP1 in t-PA regulation could be linked to the fact that a polymorphism located in the SP1 binding motif on the t-PA promoter alters t-PA response to retinoids [41] . [37, 42, 43] and strengthened the global effects of retinoids on the t-PA system in the amniotic environment.
In 
